Nexentis Technologies

NXTS · NASDAQ

$0.6153−$0.0251 (−3.92%)TodayMarket closed · Oct 20, 7:52 PM ET

Prev close $0.6404

About NXTS

Nexentis Technologies, Inc. is a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech. The company employs 7 full-time employees The company went IPO on 2010-05-26. Through its subsidiary MitoCareX Bio Ltd. The firm uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. The company enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.

Employees: 7
Headquarters: New York City, New York
Listed: May 26, 2010
Sector: Materials
Industry: Chemicals
Website: n2off.com

Leadership

Nexentis Technologies executives
Name	Title	Since	Age
Amitay Weiss	—	—	71
David Palach	—	—	57
Lital Barda	—	—	36
Dan Sztybel	—	—	46
Shlomo Zakai	—	2021	53
Asaf Itzhaik	—	—	51
Liat Sidi	—	—	47
Eliahou Arbib	—	—	56
Israel Berenshtein	—	—	52
Udi Kalifi	—	—	44
Ronen Rosenbloom	—	—	51

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.